Liver Failure, Acute on Chronic
10
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (10)
MSC-EV in Acute-on-Chronic Liver Failure After Liver Transplantation
S100A8/A9 and Innate Immunity in Liver Disease
The Efficacy and Safety of Rifaximin Treatment
Citrate Pharmacokinetics in Critically Ill Liver Failure Patients Receiving CRRT
HEpatic Regeneration With COupled Plasma Filtration and Adsorption for Liver Extracorporeal Detoxification
A Validation Cohort for ACLF Diagnosis and Prognosis
Chinese CLIF-C Acute-on-Chronic Liver Disease and Liver Failure Study
Safety and Efficacy of Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure
A Retrospective Multicenter Study of HBV-related Pre-acute-on-chronic Liver Failure in China
A Prospective Study of Evaluation of Minor Bleeding and Utility of Bleeding Criteria in Acute-on-chronic Liver Failure Patients in China